 | • レポートコード：MRC2012A0634 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アルガトロバンの世界市場を広く調査・分析し、今後の市場展望をまとめております。アルガトロバンの種類別市場規模（アルガトロバン粉末、アルガトロバン注射）、用途別市場規模（ヘパリン起因性血小板減少症（HIT）、経皮的冠動脈インターベンション、脳動脈血栓症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer, Inc、WEST-WARD,INC、fresenius-kabi、SANDOZ、Teva Pharmaceutical Industries Ltd、GlaxoSmithKline Plc、Mitsubishi Tanabe Pharma、Eagle Pharmaceuticals, Inc、 ・地域別グローバル市場分析 2015年-2020年 ・アルガトロバンの北米市場（アメリカ、カナダ、メキシコ） ・アルガトロバンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アルガトロバンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アルガトロバンの南米市場（ブラジル、アルゼンチン） ・アルガトロバンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アルガトロバン粉末、アルガトロバン注射 ・用途別分析：ヘパリン起因性血小板減少症（HIT）、経皮的冠動脈インターベンション、脳動脈血栓症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Argatroban market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Argatroban market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -14.4%% in the forecast period of 2020 to 2025 and will expected to reach USD 33 million by 2025, from USD 62 million in 2019.
Market segmentation
Argatroban market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Argatroban market has been segmented into
Argatroban Powder
Argatroban Injection
By Application, Argatroban has been segmented into:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Argatroban market presented in the report. This section sheds light on the sales growth of different regional and country-level Argatroban markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Argatroban market.
The report offers in-depth assessment of the growth and other aspects of the Argatroban market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Argatroban Market Share Analysis
Argatroban competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Argatroban sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Argatroban sales, revenue and market share for each player covered in this report.
The major players covered in Argatroban are:
Pfizer, Inc
WEST-WARD,INC
fresenius-kabi
SANDOZ
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline Plc
Mitsubishi Tanabe Pharma
Eagle Pharmaceuticals, Inc
Among other players domestic and global, Argatroban market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Argatroban product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Argatroban, with price, sales, revenue and global market share of Argatroban in 2018 and 2019.
Chapter 3, the Argatroban competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Argatroban breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Argatroban sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Argatroban Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Argatroban Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Argatroban Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Heparin-induced thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral arterial thrombosis
1.4 Overview of Global Argatroban Market
1.4.1 Global Argatroban Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc
2.1.1 Pfizer, Inc Details
2.1.2 Pfizer, Inc Major Business
2.1.3 Pfizer, Inc SWOT Analysis
2.1.4 Pfizer, Inc Product and Services
2.1.5 Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 WEST-WARD,INC
2.2.1 WEST-WARD,INC Details
2.2.2 WEST-WARD,INC Major Business
2.2.3 WEST-WARD,INC SWOT Analysis
2.2.4 WEST-WARD,INC Product and Services
2.2.5 WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 fresenius-kabi
2.3.1 fresenius-kabi Details
2.3.2 fresenius-kabi Major Business
2.3.3 fresenius-kabi SWOT Analysis
2.3.4 fresenius-kabi Product and Services
2.3.5 fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 SANDOZ
2.4.1 SANDOZ Details
2.4.2 SANDOZ Major Business
2.4.3 SANDOZ SWOT Analysis
2.4.4 SANDOZ Product and Services
2.4.5 SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd
2.5.1 Teva Pharmaceutical Industries Ltd Details
2.5.2 Teva Pharmaceutical Industries Ltd Major Business
2.5.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Product and Services
2.6.4 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mitsubishi Tanabe Pharma
2.7.1 Mitsubishi Tanabe Pharma Details
2.7.2 Mitsubishi Tanabe Pharma Major Business
2.7.3 Mitsubishi Tanabe Pharma Product and Services
2.7.4 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eagle Pharmaceuticals, Inc
2.8.1 Eagle Pharmaceuticals, Inc Details
2.8.2 Eagle Pharmaceuticals, Inc Major Business
2.8.3 Eagle Pharmaceuticals, Inc Product and Services
2.8.4 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Argatroban Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Argatroban Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Argatroban Manufacturer Market Share in 2019
3.3.2 Top 6 Argatroban Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Argatroban Sales, Revenue and Market Share by Regions
4.1.1 Global Argatroban Sales and Market Share by Regions (2015-2020)
4.1.2 Global Argatroban Revenue and Market Share by Regions (2015-2020)
4.2 North America Argatroban Sales and Growth Rate (2015-2020)
4.3 Europe Argatroban Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Argatroban Sales and Growth Rate (2015-2020)
4.5 South America Argatroban Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Argatroban Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Argatroban Sales, Revenue and Market Share by Country
5.1.1 North America Argatroban Sales and Market Share by Country (2015-2020)
5.1.2 North America Argatroban Revenue and Market Share by Country (2015-2020)
5.2 United States Argatroban Sales and Growth Rate (2015-2020)
5.3 Canada Argatroban Sales and Growth Rate (2015-2020)
5.4 Mexico Argatroban Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Argatroban Sales, Revenue and Market Share by Country
6.1.1 Europe Argatroban Sales and Market Share by Country (2015-2020)
6.1.2 Europe Argatroban Revenue and Market Share by Country (2015-2020)
6.2 Germany Argatroban Sales and Growth Rate (2015-2020)
6.3 UK Argatroban Sales and Growth Rate (2015-2020)
6.4 France Argatroban Sales and Growth Rate (2015-2020)
6.5 Russia Argatroban Sales and Growth Rate (2015-2020)
6.6 Italy Argatroban Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Argatroban Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Argatroban Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Argatroban Revenue and Market Share by Regions (2015-2020)
7.2 China Argatroban Sales and Growth Rate (2015-2020)
7.3 Japan Argatroban Sales and Growth Rate (2015-2020)
7.4 Korea Argatroban Sales and Growth Rate (2015-2020)
7.5 India Argatroban Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Argatroban Sales and Growth Rate (2015-2020)
7.7 Australia Argatroban Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Argatroban Sales, Revenue and Market Share by Country
8.1.1 South America Argatroban Sales and Market Share by Country (2015-2020)
8.1.2 South America Argatroban Revenue and Market Share by Country (2015-2020)
8.2 Brazil Argatroban Sales and Growth Rate (2015-2020)
8.3 Argentina Argatroban Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Argatroban Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Argatroban Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Argatroban Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Argatroban Sales and Growth Rate (2015-2020)
9.3 Turkey Argatroban Sales and Growth Rate (2015-2020)
9.4 Egypt Argatroban Sales and Growth Rate (2015-2020)
9.5 South Africa Argatroban Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Argatroban Sales and Market Share by Type (2015-2020)
10.2 Global Argatroban Revenue and Market Share by Type (2015-2020)
10.3 Global Argatroban Price by Type (2015-2020)
11 Global Argatroban Market Segment by Application
11.1 Global Argatroban Sales Market Share by Application (2015-2020)
11.2 Global Argatroban Revenue Market Share by Application (2015-2020)
11.3 Global Argatroban Price by Application (2015-2020)
12 Market Forecast
12.1 Global Argatroban Sales, Revenue and Growth Rate (2021-2025)
12.2 Argatroban Market Forecast by Regions (2021-2025)
12.2.1 North America Argatroban Market Forecast (2021-2025)
12.2.2 Europe Argatroban Market Forecast (2021-2025)
12.2.3 Asia-Pacific Argatroban Market Forecast (2021-2025)
12.2.4 South America Argatroban Market Forecast (2021-2025)
12.2.5 Middle East & Africa Argatroban Market Forecast (2021-2025)
12.3 Argatroban Market Forecast by Type (2021-2025)
12.3.1 Global Argatroban Sales Forecast by Type (2021-2025)
12.3.2 Global Argatroban Market Share Forecast by Type (2021-2025)
12.4 Argatroban Market Forecast by Application (2021-2025)
12.4.1 Global Argatroban Sales Forecast by Application (2021-2025)
12.4.2 Global Argatroban Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Argatroban Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Argatroban by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Argatroban Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Argatroban Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc Argatroban Major Business
Table 10. Pfizer, Inc Argatroban Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer, Inc SWOT Analysis
Table 12. Pfizer, Inc Argatroban Product and Services
Table 13. Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. WEST-WARD,INC Basic Information, Manufacturing Base and Competitors
Table 15. WEST-WARD,INC Argatroban Major Business
Table 16. WEST-WARD,INC Argatroban Total Revenue (USD Million) (2018-2019)
Table 17. WEST-WARD,INC SWOT Analysis
Table 18. WEST-WARD,INC Argatroban Product and Services
Table 19. WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table 21. fresenius-kabi Argatroban Major Business
Table 22. fresenius-kabi Argatroban Total Revenue (USD Million) (2018-2019)
Table 23. fresenius-kabi SWOT Analysis
Table 24. fresenius-kabi Argatroban Product and Services
Table 25. fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 27. SANDOZ Argatroban Major Business
Table 28. SANDOZ Argatroban Total Revenue (USD Million) (2018-2019)
Table 29. SANDOZ SWOT Analysis
Table 30. SANDOZ Argatroban Product and Services
Table 31. SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 33. Teva Pharmaceutical Industries Ltd Argatroban Major Business
Table 34. Teva Pharmaceutical Industries Ltd Argatroban Total Revenue (USD Million) (2018-2019)
Table 35. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 36. Teva Pharmaceutical Industries Ltd Argatroban Product and Services
Table 37. Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Plc Argatroban Major Business
Table 40. GlaxoSmithKline Plc Argatroban Total Revenue (USD Million) (2018-2019)
Table 41. GlaxoSmithKline Plc SWOT Analysis
Table 42. GlaxoSmithKline Plc Argatroban Product and Services
Table 43. GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Mitsubishi Tanabe Pharma Argatroban Major Business
Table 46. Mitsubishi Tanabe Pharma Argatroban Total Revenue (USD Million) (2018-2019)
Table 47. Mitsubishi Tanabe Pharma SWOT Analysis
Table 48. Mitsubishi Tanabe Pharma Argatroban Product and Services
Table 49. Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Eagle Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 51. Eagle Pharmaceuticals, Inc Argatroban Major Business
Table 52. Eagle Pharmaceuticals, Inc Argatroban Total Revenue (USD Million) (2018-2019)
Table 53. Eagle Pharmaceuticals, Inc SWOT Analysis
Table 54. Eagle Pharmaceuticals, Inc Argatroban Product and Services
Table 55. Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Argatroban Sales by Manufacturer (2018-2019) (g)
Table 57. Global Argatroban Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Argatroban Sales by Regions (2015-2020) (g)
Table 59. Global Argatroban Sales Market Share by Regions (2015-2020)
Table 60. Global Argatroban Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Argatroban Sales by Countries (2015-2020) (g)
Table 62. North America Argatroban Sales Market Share by Countries (2015-2020)
Table 63. North America Argatroban Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Argatroban Revenue Market Share by Countries (2015-2020)
Table 65. Europe Argatroban Sales by Countries (2015-2020) (g)
Table 66. Europe Argatroban Sales Market Share by Countries (2015-2020)
Table 67. Europe Argatroban Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Argatroban Sales by Regions (2015-2020) (g)
Table 69. Asia-Pacific Argatroban Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Argatroban Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Argatroban Sales by Countries (2015-2020) (g)
Table 72. South America Argatroban Sales Market Share by Countries (2015-2020)
Table 73. South America Argatroban Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Argatroban Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Argatroban Sales by Countries (2015-2020) (g)
Table 76. Middle East & Africa Argatroban Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Argatroban Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Argatroban Revenue Market Share by Countries (2015-2020)
Table 79. Global Argatroban Sales by Type (2015-2020) (g)
Table 80. Global Argatroban Sales Share by Type (2015-2020)
Table 81. Global Argatroban Revenue by Type (2015-2020) (USD Million)
Table 82. Global Argatroban Revenue Share by Type (2015-2020)
Table 83. Global Argatroban Sales by Application (2015-2020) (g)
Table 84. Global Argatroban Sales Share by Application (2015-2020)
Table 85. Global Argatroban Sales Forecast by Regions (2021-2025) (g)
Table 86. Global Argatroban Market Share Forecast by Regions (2021-2025)
Table 87. Global Argatroban Sales Forecast by Type (2021-2025) (g)
Table 88. Global Argatroban Market Share Forecast by Type (2021-2025)
Table 89. Global Argatroban Sales Forecast by Application (2021-2025)
Table 90. Global Argatroban Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Argatroban Picture
Figure 2. Global Sales Market Share of Argatroban by Type in 2019
Figure 3. Argatroban Powder Picture
Figure 4. Argatroban Injection Picture
Figure 5. Argatroban Sales Market Share by Application in 2019
Figure 6. Heparin-induced thrombocytopenia (HIT) Picture
Figure 7. Percutaneous Coronary Intervention Picture
Figure 8. Cerebral arterial thrombosis Picture
Figure 9. Global Argatroban Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Argatroban Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Argatroban Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Argatroban Sales Market Share by Manufacturer in 2019
Figure 30. Global Argatroban Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Argatroban Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Argatroban Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 35. Global Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Argatroban Revenue Market Share by Regions (2015-2020)
Figure 37. Global Argatroban Revenue Market Share by Regions in 2018
Figure 38. North America Argatroban Sales and Growth Rate (2015-2020)
Figure 39. Europe Argatroban Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Argatroban Sales and Growth Rate (2015-2020)
Figure 41. South America Argatroban Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Argatroban Sales and Growth Rate (2015-2020)
Figure 43. North America Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Argatroban Sales Market Share by Countries (2015-2020)
Figure 45. North America Argatroban Sales Market Share by Countries in 2018
Figure 46. North America Argatroban Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Argatroban Revenue Market Share by Countries in 2018
Figure 48. United States Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 49. Canada Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 50. Mexico Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 51. Europe Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Argatroban Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Argatroban Revenue Market Share by Countries in 2019
Figure 54. Germany Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 55. UK Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 56. France Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 57. Russia Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 58. Italy Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 59. Asia-Pacific Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Argatroban Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Argatroban Revenue Market Share by Regions 2019
Figure 62. China Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 63. Japan Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 64. Korea Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 65. India Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 66. Southeast Asia Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 67. South America Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Argatroban Sales Market Share by Countries in 2019
Figure 69. South America Argatroban Revenue Market Share by Countries in 2019
Figure 70. Brazil Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 71. Argentina Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 72. Middle East and Africa Argatroban Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Argatroban Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Argatroban Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Argatroban Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 77. Egypt Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 78. Turkey Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 79. South Africa Argatroban Sales and Growth Rate (2015-2020) (g)
Figure 80. Global Argatroban Sales and Growth Rate (2021-2025) (g)
Figure 81. Global Argatroban Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Argatroban Market Forecast (2021-2025) (g)
Figure 83. Europe Sales Argatroban Market Forecast (2021-2025) (g)
Figure 84. Asia-Pacific Sales Argatroban Market Forecast (2021-2025) (g)
Figure 85. South America Sales Argatroban Market Forecast (2021-2025) (g)
Figure 86. Middle East & Africa Sales Argatroban Market Forecast (2021-2025) (g)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
経皮的冠動脈インターベンションの世界市場（～2026年） Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visual…- 経皮経管冠動脈形成術（PTCA）製品の世界市場（～2026年） Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle. Market Analysis and Insights: Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market The g…
- 動脈血栓症薬の世界市場（～2026年） Market Analysis and Insights: Global Arterial Thrombosis Drug Market The global Arterial Thrombosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Arterial Thrombosis Drug Scope and Market Size Arterial Thrombosi…
- 生体吸収性冠動脈ステントの世界市場（～2026年） Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these ful…
- 神経血管介入装置の世界市場（～2026年） Neurovascular intervention is a technique that treats any disease or injury without surgery, usually in areas of high risk or high mortality such as the spine, brain or neck. The main target market is in North America, followed by Europe. Asia-Pacific region is expected to grow due to the large popu…